EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease via AMPK /Nrf2 elevation

Ji-Mu Wu, Getu Zhaori, Li Mei, Xiao-Man Ren, Arong Tong Laga, Batu Deligen iD

The Kaohsiung Journal of Medical Sciences · 2023

DOI: 10.1002/kjm2.12712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2023. Verfasst von Ji-Mu Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonalcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome with a rapidly increasing prevalence globally. Plantamajoside (PMS), a phenylethanoid glycoside component extracted from Plantago asiatica , has various biological properties. However, its effect on NAFLD remains unknown. The study aimed to explore the effect and mechanism of PMS on NAFLD in the high‐fat diet (HFD)‐feeding rats. PMS induced a decrease in body and liver weight, and the amelioration in the blood lipid parameters and pathological symptoms in HFD‐feeding rats. The increase in the serum concentrations and the relative protein expressions of proinflammatory factors was decreased by the PMS treatment in HFD‐induced NAFLD rats. Additionally, PMS reduced the excessive lipid vacuoles, and modified the relative expressions of proteins involved in the fatty acid synthesis and uptake in HFD‐feeding rats. Mechanically, the downregulation of AMPK/Nrf2 pathway in HFD‐feeding rats was restored by the PMS treatment. Inhibition of AMPK pathway reversed the PMS‐induced the increase in the level of inflammatory factors, pathological symptoms, excessive lipid vacuoles, and the relative expression of proteins involved in the fatty acid synthesis and uptake. Collectively, PMS ameliorated immune dysregulation and abnormal hepatic lipid metabolism by activating AMPK/Nrf2 pathway in rats with NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAnimalsRatsAMP-Activated Protein KinasesFatty AcidsLipid MetabolismLipidsLiverNF-E2-Related Factor 2CatecholsGlucosides

Stichwörter der Autor:innen

AMPK/Nrf2hepatic lipid metabolismimmune deregulationnonalcoholic fatty liver diseaseplantamajoside

Substanzen

AMP-Activated Protein KinasesFatty AcidsLipidsNF-E2-Related Factor 2plantamajosideCatecholsGlucosides

Autor:innen und Institutionen

  • Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Minzu University, Tongliao, China.

ORCID-Profile: Batu Deligen

Zitieren

APA

Wu, J. M., Zhaori, G., Mei, L., Ren, X. M., Laga, A. T., & Deligen, B. (2023). Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease via AMPK /Nrf2 elevation. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12712

Vancouver

Wu JM, Zhaori G, Mei L, Ren XM, Laga AT, Deligen B. Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease via AMPK /Nrf2 elevation. The Kaohsiung Journal of Medical Sciences. 2023. doi:10.1002/kjm2.12712

BibTeX
@article{Wu2023,
  author = {Wu, Ji-Mu and Zhaori, Getu and Mei, Li and Ren, Xiao-Man and Laga, Arong Tong and Deligen, Batu},
  title = {Plantamajoside modulates immune dysregulation and hepatic lipid metabolism in rats with nonalcoholic fatty liver disease via AMPK /Nrf2 elevation},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2023},
  doi = {10.1002/kjm2.12712}
}
Kostenlos starten →